-- Shilpa Medicare (NSE:SHILPAMED, BOM:530549) has appointed Vellaian Karuppiah as the chief operating officer of formulations, with effect from Thursday, according to a same-day filing to the Indian stock exchanges.
Karuppiah held several high-level positions in various pharmaceutical organizations, including Gland Pharma, Strides Group, Dr. Reddy's Laboratories, Actavis, and Orchid Healthcare, among others.
The company's shares were up nearly 3% in recent trade.